Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Singapore Institute of Advanced Medicine Holdings Ltd. has entered into a key partnership with Australian biopharmaceutical company EnGeneIC to manufacture and distribute advanced anti-cancer products in Asia and develop cutting-edge cancer theranostics. Under this strategic alliance, EnGeneIC will establish a manufacturing plant in Singapore and lead clinical trials, while the Singaporean company secures exclusive distribution rights in 17 Asian countries. Joint efforts will focus on leveraging EnGeneIC’s proprietary technology to advance cancer treatment and share profits from the sales of these innovative products.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.
